öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÌÀ·æ
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º78

ËùÊôԺУ£ºÇຣ´óѧ
ËùÊôԺϵ£ºÒ½Ñ§Ôº
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÃâÒßѧ
Ñо¿ÁìÓò£º ±íλÒßÃçµÄÑÐÖÆÓëҩЧѧÆÀ¼Û
Ñо¿ÁìÓò£º ±íλÒßÃçµÄÑÐÖÆÓëҩЧѧÆÀ¼Û [ÊÕÆð]




¸öÈ˼òÊö :
¸öÈ˼òÀú£º
ÌÀ·æ£¬ÄУ¬Öй²²úµ³Ô±¡£Àíѧ²©Ê¿£¬¸±½ÌÊÚ£¬Ë¶Ê¿Éúµ¼Ê¦£¬Çຣ´óѧ¸ßԭҽѧÑо¿ÖÐÐÄÈËÐó¹²»¼²¡»ù´¡Ñо¿ÊÒ¸±Ö÷ÈΣ¬ÇຣʡÒý½ø¸ß²ã´ÎÈ˲ÅÖ÷ÒªÖÂÁ¦ÓÚ¸ßԭҽѧ¡¢ÈËÐó¹²»¼²¡µÄÁÙ´²Óë»ù´¡Ñо¿¡£Ä¿Ç°Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð1Ïî¡¢Çຣʡ×ÔÈ»¿Æѧ»ù½ð1Ïî¡£²ÎÓë973ÏîÄ¿1Ï¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿2ÏÇຣʡ×ÔÈ»¿Æѧ»ù½ðÏîÄ¿2Ïî¡£ÔÚ¹úÄÚÍâÆÚ¿¯·¢±í¿ÆÑÐÂÛÎÄ20Óàƪ£¬ÆäÖÐSCIÂÛÎÄ11ƪ¡£



¿ÆÑй¤×÷ :
Ñо¿ÄÚÈݼò½é£º
´ÓʱíλÒßÃçµÄÑо¿¡¢microRNAÓë¸ßÔ­²¡µÄÑо¿¡¢²ØÒ©Óë°ü³æ²¡ÖÎÁƵÄÑо¿¡£

³¤ÆÚ´ÓÊ°ü³æ²¡µÄÒßÃçÑо¿¼°°ü³æ²¡ÔçÆÚÕï¶ÏÊÔ¼ÁºÐµÄÑз¢£¬Ä¿Ç°Òѳõ²½½¨Á¢ÁË´ÓÍâÖÜѪѭ»·DNAÔçÆÚ¼ì²â°ü³æ²¡µÄ·½·¨£»Í¬Ê±Ñо¿²ØÒ©¶Ô°ü³æ²¡ÖÎÁƵÄÁÆЧ¼°ÆÀ¼Û£¬³õ²½Ñо¿·¢ÏÖ¾ÃÃÀ²ØÒ©¡¢¸ñ¶ûÇíµÈ²ØÒ©¶Ô¿¹°ü³æ²¡ÓÐÒ»¶¨µÄÁÆЧ¡£Í¬Ê±Ñо¿miRNAÔÚÂýÐÔµÍÑõÊÊÓ¦¹ý³ÌÖжÔÔìѪϵͳµ÷¿ØµÄ»úÖÆÑо¿¡£
ÔÚÑпÆÑÐÏîÄ¿£º
°´ÐòºÅ¡¢ÏîÄ¿Ãû³Æ¡¢ÏîÄ¿À´Ô´¡¢¾­·Ñ£¨ÍòÔª£©¡¢Æðֹʱ¼ä·ÖÐÐÌîд£¨Ìرð˵Ã÷ÊÇÔÚÑÐÏîÄ¿£©

1.¡¶miR-122 ÔÚµ÷¿Ø²Ø×åµÍÑõÊÊÓ¦¹ý³ÌÖеķÖ×Ó»úÖÆÑо¿¡·£¬¹ú¼Ò×ÔÈ»»ù½ðίԱ»á£¬49ÍòÔª£¬2014.01-2017.12

2£®¡¶»ùÓÚÍøÂçÒ©Àíѧ¶Ô²ØÒ©ËÄζÀ±¸ù²ËÌÀÉ¢¿¹ÂýÐÔȱÑõÐÔÆø¹ÜÑ×Ö¢µÄҩЧÎïÖÊ»ù´¡¼°×÷ÓûúÖÆÑо¿¡·£¬¹ú¼Ò×ÔÈ»»ù½ðίԱ»á£¬47ÍòÔª£¬2015.01-2018.12

3.¡¶¸ßÔ­ÊÊÓ¦ÓëÂýÐÔ¸ßÔ­²¡¹ØÁªµÄÕýÑ¡»ùÒòÉúÎïѧ¹¦ÄÜÑо¿¡·£¬¹ú¼Ò×ÔÈ»»ù½ðίԱ»á£¬75.6ÍòÔª£¬2016.01-2019.12

4£®¡¶ÐÂÐͶ෿¼¬Çòòʶà±íλÒßÃç CTB-AE µÄÑÐÖÆ»ù´¡Ñо¿¡·£¬Çຣʡ¿Æ¼¼Ìü£¬ÍòÔª£¬2014.09-2017.09

5.¡¶¶à·¿¼¬ÇòòÊÖØ×éÑǵ¥Î»ÒßÃç LTB-EMY162 µÄÃâÒßѧÓëҩЧѧÆÀ¼Û¡·£¬Çຣʡ¿Æ¼¼Ìü£¬18ÍòÔª£¬2015.07-2017.12
ѧÊõÂÛÎÄ£º
Ò»¡¢±¾ÈË·¢±íÂÛÎÄ£¨°´ÐòºÅ¡¢Ç°Èý×÷ÕßÐÕÃû¡¢ÂÛÎÄÌâÄ¿¡¢·¢±í¿¯ÎïÃû³Æ¡¢·¢±íʱ¼ä·ÖÐÐÌîд£¬ÏÞ½ü5Äê·¢±íµÄÎÄÕ£©

[1]Tang F, Zhang R, He Y, Zou M, Guo L, Xi T. MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells. PLoS One. 2012. 7(5): e35435.

[2]Tashi T, Feng T, Koul P, et al. High altitude genetic adaptation in Tibetans: no role of increased hemoglobin-oxygen affinity. Blood Cells Mol Dis. 2014. 53(1-2): 27-9.

[3]Guo L, Li X, Tang F, et al. Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit. Appl Microbiol Biotechnol. 2012. 93(5): 1937-45.

[4]Guo L, Liu K, Zhao W, et al. Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model. Appl Microbiol Biotechnol. 2013. 97(6): 2367-78.

[5]Tu J, Xing Y, Guo Y, Tang F, Guo L, Xi T. TanshinoneIIA ameliorates inflammatory microenvironment of colon cancer cells via repression of microRNA-155. Int Immunopharmacol. 2012. 14(4): 353-61.

[6]Gai XY, Tang F, Ma J, et al. Antiproliferative effect of echinacoside on rat pulmonary artery smooth muscle cells under hypoxia. J Pharmacol Sci. 2014. 126(2): 155-63.

[7]Deng L, Zhang R, Tang F, Li C, Xing YY, Xi T. Ursolic acid induces U937 cells differentiation by PI3K/Akt pathway activation. Chin J Nat Med. 2014. 12(1): 15-9.

[8]Zhao YX, Tang F, Ga Q, et al. High fat diet exacerbates vascular endothelial dysfunction in rats exposed to continuous hypobaric hypoxia. Biochem Biophys Res Commun. 2015. 457(3): 485-91.

[9]Xu J, Yang YZ, Tang F, et al. CYP17A1 and CYP2E1 variants associated with high altitude polycythemia in Tibetans at the Qinghai-Tibetan Plateau. Gene. 2015. 566(2): 257-63.

[10] Xu J, Yang YZ, Tang F, Ga Q, Tana W, Ge RL. EPAS1 Gene Polymorphisms Are Associated With High Altitude Polycythemia in Tibetans at the Qinghai-Tibetan Plateau. Wilderness Environ Med. 2015. 26(3): 288-94.

[11]ÌÀ·æ, ÁõÀ¥Ã·, ÀîÈóÀÖ, ÞÉÌÎ. ¾ºÕùÐÔÄÚÔ´RNA(ceRNAs)Ñо¿½øÕ¹¡ª¡ªRNA¶Ô»°µÄлúÖÆ. ÖйúÒ©¿Æ´óѧѧ±¨. 2012. (06).

[12]ÌÀ·æ, Ñîçå, ÀîÈóÀÖ, ¸ñÈÕÁ¦, ÞÉÌÎ. Îȶ¨¹ý±í´ïmiR-125b¶ÔÈéÏÙ°©MCF-7ϸ°ûתÒÆÄÜÁ¦µÄÓ°Ïì. ҩѧ½øÕ¹. 2014. (01).

[13]ÌÀ·æ, ¸ÂÇÙ, ÀîÈóÀÖ, ¸ñÈÕÁ¦, ÞÉÌÎ. ÂãÊó½üºìÍâÖ×ÁöÌåÄÚתÒÆÄ£Ð͵Ľ¨Á¢. ÇຣҽѧԺѧ±¨. 2013. (04).

[14]ÌÀ·æ, ÖÜæµ, ÑÃ÷, Ðí¼¤Ñï, ÀîÈóÀÖ. Âó½Ç¹Ì´¼ºÏ³ÉÒÖÖƼÁ¶Ô´Ù½øºì½ÍĸÀÛ»ý·¬ÇѺìËصÄÑо¿. Ò©ÎïÉúÎï¼¼Êõ. 2009. (01).

[15]ÈÎÌìÄê, ºÎÚSÃà, ÌÀ·æ, ÕÅæÃ, Éò¾§, ÞÉÌÎ. SMYD3µ÷¿ØÈËÈéÏÙ°©MCF-7ϸ°ûÔöÖ³»úÖƵÄÑо¿. ҩѧ½øÕ¹. 2012. (02).

¶þ¡¢Ñо¿Éú·¢±íÂÛÎÄ£¨°´ÐòºÅ¡¢Ç°Èý×÷ÕßÐÕÃû¡¢ÂÛÎÄÌâÄ¿¡¢·¢±í¿¯ÎïÃû³Æ¡¢·¢±íʱ¼ä·ÖÐÐÌîд£¬ÏÞ10ƪ£©

[1]ÅÓÃ÷Ȫ, ÌÀ·æ, ÖÜ»¢, Íò³Â·É, Ñôµ¤²ÅÈÃ, ·®º£Äþ. ¶à·¿¼¬ÇòòÊ¿¹Ô­µ°°×TSP3¿¹Ô­±íλµÄÉúÎïÐÅϢѧԤ²â. ÇຣҽѧԺѧ±¨. 2016. (01).

[2]ÖÜ»¢, ÌÀ·æ, ÅÓÃ÷ȪµÈ. ¶à·¿¼¬ÇòòÊÖØ×éµ°°×CTB-Emy162µÄÔ­ºË±í´ï¼°·ÖÀë´¿»¯. ÇຣҽѧԺѧ±¨. 2016. (01).